Company PROCEPT BioRobotics, producing a surgical mechanized system for minimally invasive surgery in the field of urology, filed an application with the Securities and Exchange Commission to raise up to 100 million dollars.
PROCEPT BioRobotics Practice Commercial Surgical Robotic Technique, aimed at increasing the productivity of patient healing through the development of revolutionary solutions in the field of urology. The company carries out the development of, manufactures and markets the AquaBeam Robotic System - a surgical mechanized system for use in minimally invasive urological surgery for the treatment of benign prostatic hyperplasia. В AquaBeam Robotic System, which was developed by the company, use disposable tip for Aquablation product delivery. According to the situation on 30 June 2021 of the year PROCEPT BioRobotics has made a base of 124 систем AquaBeam Robotic Systems, and Aquablation was consumed more during treatment 5500 patients.
Company headquartered in Redwood City, California, was founded in 2009 year, and for 12 Months, ended 30 June 2021 of the year, the amount of its sales was 21 million dollars. The company plans to list on the stock exchange Nasdaq under the ticker PRCT. BofA Securities became the collective arrangers of the share issue, Goldman Sachs, Cowen, Guggenheim Securities и SVB Leerink. Terms of the upcoming IPO were not disclosed.
